Human beta-defensins: Differential activity against candidal species and regulation by Candida albicans

Journal of Dental Research

Volumn 84, Issue 5, 2005, Pages 445-450

  Feng, Z ^a   Jiang, B ^a   Chandra, J ^b   Ghannoum, M ^b   Nelson, S ^a   Weinberg, A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta defensins; Candida; Innate immunity; Oral epithelial cells

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN; BETA DEFENSIN 3; BETA-DEFENSIN 3; DEFB1 PROTEIN, HUMAN; DEFB4 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL ADHESION; CELL CULTURE; CELL LINE; CELL MEMBRANE; CLASSIFICATION; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN; MOUTH MUCOSA;

ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL ADHESION; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; DRUG RESISTANCE, FUNGAL; EPITHELIAL CELLS; HUMANS; MICROSCOPY, CONFOCAL; MOUTH MUCOSA; RECOMBINANT PROTEINS;

EID: 21744462099     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508400509     Document Type: Article

References (31)

1. Cormack BP, Ghori N, Falkow S (1999). An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285:578-582.
2. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447.
3. Edgerton M, Koshlukova SE, Araujo MW, Patel RC, Dong J, Bruenn JA (2000). Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 44:3310-3316.
4. Feucht E, DeSanti CL, Weinberg A (2003). Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol Immunol 18:1-5.
5. Fidel PL Jr (2002). Immunity to Candida. Oral Dis 8(Suppl 2):69-75.
6. Folwaczny C, Glas J, Torok HP (2003). Crohn's disease: an immunodeficiency? Eur J Gastroenterol Hepatol 15:621-626.
7. Ghannoum MA, Radwan SS (1990). Candida adherence to epithelial cells. Boca Raton, FL: CRC Press.
8. Gillum AM, Tsay EY, Kirsch DR (1984). Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198:179-182.
9. Gorter AD, Oostrik J, van der Ley P, Hiemstra PS, Dankert J, van Alphen L (2003). Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog 34:121-130.
10. Harder J, Bartels J, Christophers E, Schroder JM (1997). A peptide antibiotic from human skin. Nature 387:861.
11. Härder J, Bartels J, Christophers E, Schroder JM (2001). Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-5713.
12. Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J (2003). Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother 47:2804-2809.
13. Huppert M, Harper G, Sun SH, Delanerolle V (1975). Rapid methods for identification of yeasts. J Clin Microbiol 2:21-34.
14. Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004). Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42:1024-1029.
15. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA (2003). Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type 1 diabetics and nondiabetic controls. J Clin Microbiol 41:90-96.
16. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA (1998). Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 66:4222-4228.
17. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA (2000). Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 68:2907-2915.
18. Li XS, Reddy MS, Baev D, Edgerton M (2003). Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem 278:28553-28561.
19. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR (1997). Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
20. Mandel ID (1972). Saliva. St. Louis: C.V. Mosby Co.
21. Nikawa H, Jin C, Fukushima H, Makihira S, Hamada T (2001). Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol 16:250-252.
22. Niyonsaba F, Ogawa H, Nagaoka I (2004). Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111:273-281.
23. Pankhurst C (2002). Oropharyngeal candidiasis. Clin Evid 7:1248-1262.
24. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, et al (2003). Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17:F39-F48.
25. Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, et al. (2004). Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:47-52.
26. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T (2002). High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22:2103-2107.
27. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB Jr, et al. (2002). The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277:8279-8289.
28. Thevissen K, Warnecke DC, Francois IE, Leipelt M, Heinz E, Ott C, et al. (2004). Defensins from insects and plants interact with fungal glucosylceramides. J Biol Chem 279:3900-3905.
29. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T (1998). Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101:1633-1642.
30. Weinberg A, Krisanaprakornkit S, Dale BA (1998). Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 9:399-414.
31. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. (1999). Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 [see comments]. Science 286:525-528.